Global Antiviral Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published: November 2022

No. of Pages: 103

Price:

Single User License: US $ 5600

Corporate User License: US $ 11200

Report Description
Table of Contents

Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiviral Drugs manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Antiviral Drugs market. Further, it explains the major drivers and regional dynamics of the global Antiviral Drugs market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Roche
- Johnson & Johnson
- Merck
- Novartis
- Bristol-Myers Squibb
- Gilead Sciences
- GlaxoSmithKline
- AbbVie

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Antiviral Drugs Segment by Type
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Immune System Modulators
Antiviral Drugs Segment by Application
- Hepatitis Therapeutics
- HIV/AIDS Therapeutics
- Herpes Therapeutics
- Influenza Therapeutics

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antiviral Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Antiviral Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Antiviral Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antiviral Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiviral Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Antiviral Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Antiviral Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Johnson & Johnson, Merck, Novartis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and AbbVie, etc.

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Antiviral Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 Fusion Inhibitors
1.2.5 Immune System Modulators
1.3 Market Segment by Application
1.3.1 Global Antiviral Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antiviral Drugs Market Size (2017-2028)
2.1.1 Global Antiviral Drugs Revenue (2017-2028)
2.1.2 Global Antiviral Drugs Sales (2017-2028)
2.2 Global Antiviral Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Antiviral Drugs Sales by Regions (2017-2022)
2.2.2 Global Antiviral Drugs Revenue by Regions (2017-2022)
2.3 Global Antiviral Drugs Market Size Forecast by Region
2.3.1 Global Antiviral Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Antiviral Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Antiviral Drugs Regions (Countries) Ranking by Market Size
2.5 Antiviral Drugs Market Dynamics
2.5.1 Antiviral Drugs Market Trends
2.5.2 Antiviral Drugs Market Drivers
2.5.3 Antiviral Drugs Market Challenges
2.5.4 Antiviral Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Antiviral Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Antiviral Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Antiviral Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Antiviral Drugs Sales in 2021
3.2 Global Top Manufacturers Antiviral Drugs by Revenue
3.2.1 Global Antiviral Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Antiviral Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Antiviral Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiviral Drugs as of 2021)
3.4 Global Antiviral Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Antiviral Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Antiviral Drugs Market
3.7 Key Manufacturers Antiviral Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antiviral Drugs Market Size by Type
4.1 Global Antiviral Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Antiviral Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Antiviral Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Antiviral Drugs Price by Type (2017-2022)
4.2 Global Antiviral Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Antiviral Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Antiviral Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Antiviral Drugs Price Forecast by Type (2023-2028)
5 Global Antiviral Drugs Market Size by Application
5.1 Global Antiviral Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Antiviral Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Antiviral Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Antiviral Drugs Price by Application (2017-2022)
5.2 Global Antiviral Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Antiviral Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Antiviral Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Antiviral Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antiviral Drugs Sales Breakdown by Company
6.1.1 North America Antiviral Drugs Sales by Company (2017-2022)
6.1.2 North America Antiviral Drugs Revenue by Company (2017-2022)
6.2 North America Antiviral Drugs Market Size by Type
6.2.1 North America Antiviral Drugs Sales by Type (2017-2028)
6.2.2 North America Antiviral Drugs Revenue by Type (2017-2028)
6.3 North America Antiviral Drugs Market Size by Application
6.3.1 North America Antiviral Drugs Sales by Application (2017-2028)
6.3.2 North America Antiviral Drugs Revenue by Application (2017-2028)
6.4 North America Antiviral Drugs Market Size by Country
6.4.1 North America Antiviral Drugs Sales by Country (2017-2028)
6.4.2 North America Antiviral Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Antiviral Drugs Sales Breakdown by Company
7.1.1 Europe Antiviral Drugs Sales by Company (2017-2022)
7.1.2 Europe Antiviral Drugs Revenue by Company (2017-2022)
7.2 Europe Antiviral Drugs Market Size by Type
7.2.1 Europe Antiviral Drugs Sales by Type (2017-2028)
7.2.2 Europe Antiviral Drugs Revenue by Type (2017-2028)
7.3 Europe Antiviral Drugs Market Size by Application
7.3.1 Europe Antiviral Drugs Sales by Application (2017-2028)
7.3.2 Europe Antiviral Drugs Revenue by Application (2017-2028)
7.4 Europe Antiviral Drugs Market Size by Country
7.4.1 Europe Antiviral Drugs Sales by Country (2017-2028)
7.4.2 Europe Antiviral Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antiviral Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Antiviral Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Antiviral Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Antiviral Drugs Market Size by Type
8.2.1 Asia Pacific Antiviral Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Antiviral Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Antiviral Drugs Market Size by Application
8.3.1 Asia Pacific Antiviral Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Antiviral Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Antiviral Drugs Market Size by Region
8.4.1 Asia Pacific Antiviral Drugs Sales by Region
8.4.2 Asia Pacific Antiviral Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Antiviral Drugs Sales Breakdown by Company
9.1.1 Latin America Antiviral Drugs Sales by Company (2017-2022)
9.1.2 Latin America Antiviral Drugs Revenue by Company (2017-2022)
9.2 Latin America Antiviral Drugs Market Size by Type
9.2.1 Latin America Antiviral Drugs Sales by Type (2017-2028)
9.2.2 Latin America Antiviral Drugs Revenue by Type (2017-2028)
9.3 Latin America Antiviral Drugs Market Size by Application
9.3.1 Latin America Antiviral Drugs Sales by Application (2017-2028)
9.3.2 Latin America Antiviral Drugs Revenue by Application (2017-2028)
9.4 Latin America Antiviral Drugs Market Size by Country
9.4.1 Latin America Antiviral Drugs Sales by Country (2017-2028)
9.4.2 Latin America Antiviral Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antiviral Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Antiviral Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Antiviral Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Antiviral Drugs Market Size by Type
10.2.1 Middle East and Africa Antiviral Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Antiviral Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Antiviral Drugs Market Size by Application
10.3.1 Middle East and Africa Antiviral Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Antiviral Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Antiviral Drugs Market Size by Country
10.4.1 Middle East and Africa Antiviral Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Antiviral Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Roche Antiviral Drugs Products and Services
11.1.5 Roche Antiviral Drugs SWOT Analysis
11.1.6 Roche Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Antiviral Drugs Products and Services
11.2.5 Johnson & Johnson Antiviral Drugs SWOT Analysis
11.2.6 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Merck Antiviral Drugs Products and Services
11.3.5 Merck Antiviral Drugs SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Novartis Antiviral Drugs Products and Services
11.4.5 Novartis Antiviral Drugs SWOT Analysis
11.4.6 Novartis Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Overview
11.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Bristol-Myers Squibb Antiviral Drugs Products and Services
11.5.5 Bristol-Myers Squibb Antiviral Drugs SWOT Analysis
11.5.6 Bristol-Myers Squibb Recent Developments
11.6 Gilead Sciences
11.6.1 Gilead Sciences Corporation Information
11.6.2 Gilead Sciences Overview
11.6.3 Gilead Sciences Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Gilead Sciences Antiviral Drugs Products and Services
11.6.5 Gilead Sciences Antiviral Drugs SWOT Analysis
11.6.6 Gilead Sciences Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Corporation Information
11.7.2 GlaxoSmithKline Overview
11.7.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 GlaxoSmithKline Antiviral Drugs Products and Services
11.7.5 GlaxoSmithKline Antiviral Drugs SWOT Analysis
11.7.6 GlaxoSmithKline Recent Developments
11.8 AbbVie
11.8.1 AbbVie Corporation Information
11.8.2 AbbVie Overview
11.8.3 AbbVie Antiviral Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 AbbVie Antiviral Drugs Products and Services
11.8.5 AbbVie Antiviral Drugs SWOT Analysis
11.8.6 AbbVie Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Antiviral Drugs Value Chain Analysis
12.2 Antiviral Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiviral Drugs Production Mode & Process
12.4 Antiviral Drugs Sales and Marketing
12.4.1 Antiviral Drugs Sales Channels
12.4.2 Antiviral Drugs Distributors
12.5 Antiviral Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Antiviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Reverse Transcriptase Inhibitors
Table 3. Major Manufacturers of Protease Inhibitors
Table 4. Major Manufacturers of Fusion Inhibitors
Table 5. Major Manufacturers of Immune System Modulators
Table 6. Global Antiviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antiviral Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Antiviral Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global Antiviral Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Antiviral Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Antiviral Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Antiviral Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 13. Global Antiviral Drugs Sales Market Share Forecast by Region (2023-2028)
Table 14. Global Antiviral Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Antiviral Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 16. Top Antiviral Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 17. Antiviral Drugs Market Trends
Table 18. Antiviral Drugs Market Drivers
Table 19. Antiviral Drugs Market Challenges
Table 20. Antiviral Drugs Market Restraints
Table 21. Global Antiviral Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Antiviral Drugs Sales Share by Manufacturers (2017-2022)
Table 23. Global Antiviral Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Ranking of Global Top Antiviral Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 25. Antiviral Drugs Revenue Share by Manufacturers (2017-2022)
Table 26. Global Antiviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiviral Drugs as of 2021)
Table 28. Key Manufacturers Antiviral Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 29. Key Manufacturers Antiviral Drugs Plants/Factories Distribution
Table 30. Key Manufacturers Antiviral Drugs Area Served
Table 31. Date of Key Manufacturers Enter into Antiviral Drugs Market
Table 32. Key Manufacturers Antiviral Drugs Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Antiviral Drugs Sales (K Units) by Type (2017-2022)
Table 35. Global Antiviral Drugs Sales Share by Type (2017-2022)
Table 36. Global Antiviral Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 37. Global Antiviral Drugs Price (K Units) by Type (2017-2022)
Table 38. Global Antiviral Drugs Sales (K Units) by Type (2023-2028)
Table 39. Global Antiviral Drugs Sales Share by Type (2023-2028)
Table 40. Global Antiviral Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 41. Global Antiviral Drugs Revenue Share by Type (2023-2028)
Table 42. Global Antiviral Drugs Price (K Units) by Type (2023-2028)
Table 43. Global Antiviral Drugs Sales (K Units) by Application (2017-2022)
Table 44. Global Antiviral Drugs Sales Share by Application (2017-2022)
Table 45. Global Antiviral Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 46. Global Antiviral Drugs Price (K Units) by Application (2017-2022)
Table 47. Global Antiviral Drugs Sales (K Units) by Application (2023-2028)
Table 48. Global Antiviral Drugs Sales Share by Application (2023-2028)
Table 49. Global Antiviral Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 50. Global Antiviral Drugs Revenue Share by Application (2023-2028)
Table 51. Global Antiviral Drugs Price (K Units) by Application (2023-2028)
Table 52. North America Antiviral Drugs Sales by Company (2017-2022) & (K Units)
Table 53. North America Antiviral Drugs Sales Market Share by Company (2017-2022)
Table 54. North America Antiviral Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 55. North America Antiviral Drugs Revenue Market Share by Company (2017-2022)
Table 56. North America Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 57. North America Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 58. North America Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 59. North America Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 60. North America Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 61. North America Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 62. North America Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 63. North America Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 64. North America Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 65. North America Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 66. North America Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 67. North America Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 68. Europe Antiviral Drugs Sales by Company (2017-2022) & (K Units)
Table 69. Europe Antiviral Drugs Sales Market Share by Company (2017-2022)
Table 70. Europe Antiviral Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 71. Europe Antiviral Drugs Revenue Market Share by Company (2017-2022)
Table 72. Europe Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 73. Europe Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 74. Europe Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 75. Europe Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 76. Europe Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Europe Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Europe Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 79. Europe Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 80. Europe Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 81. Europe Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 82. Europe Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 83. Europe Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 84. Asia Pacific Antiviral Drugs Sales by Company (2017-2022) & (K Units)
Table 85. Asia Pacific Antiviral Drugs Sales Market Share by Company (2017-2022)
Table 86. Asia Pacific Antiviral Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 87. Asia Pacific Antiviral Drugs Revenue Market Share by Company (2017-2022)
Table 88. Asia Pacific Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 89. Asia Pacific Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 90. Asia Pacific Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 91. Asia Pacific Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 92. Asia Pacific Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 93. Asia Pacific Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Asia Pacific Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 95. Asia Pacific Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 96. Asia Pacific Antiviral Drugs Sales by Region (2017-2022) & (K Units)
Table 97. Asia Pacific Antiviral Drugs Sales by Region (2023-2028) & (K Units)
Table 98. Asia Pacific Antiviral Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 99. Asia Pacific Antiviral Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 100. Latin America Antiviral Drugs Sales by Company (2017-2022) & (K Units)
Table 101. Latin America Antiviral Drugs Sales Market Share by Company (2017-2022)
Table 102. Latin America Antiviral Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 103. Latin America Antiviral Drugs Revenue Market Share by Company (2017-2022)
Table 104. Latin America Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 105. Latin America Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 106. Latin America Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 107. Latin America Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 108. Latin America Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 109. Latin America Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Latin America Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 111. Latin America Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 112. Latin America Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 113. Latin America Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 114. Latin America Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 115. Latin America Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 116. Middle East and Africa Antiviral Drugs Sales by Company (2017-2022) & (K Units)
Table 117. Middle East and Africa Antiviral Drugs Sales Market Share by Company (2017-2022)
Table 118. Middle East and Africa Antiviral Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Antiviral Drugs Revenue Market Share by Company (2017-2022)
Table 120. Middle East and Africa Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 121. Middle East and Africa Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 122. Middle East and Africa Antiviral Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Antiviral Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 124. Middle East and Africa Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 125. Middle East and Africa Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 126. Middle East and Africa Antiviral Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Antiviral Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 129. Middle East and Africa Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 130. Middle East and Africa Antiviral Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Antiviral Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 132. Roche Corporation Information
Table 133. Roche Description and Overview
Table 134. Roche Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 135. Roche Antiviral Drugs Product and Services
Table 136. Roche Antiviral Drugs SWOT Analysis
Table 137. Roche Recent Developments
Table 138. Johnson & Johnson Corporation Information
Table 139. Johnson & Johnson Description and Overview
Table 140. Johnson & Johnson Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 141. Johnson & Johnson Antiviral Drugs Product and Services
Table 142. Johnson & Johnson Antiviral Drugs SWOT Analysis
Table 143. Johnson & Johnson Recent Developments
Table 144. Merck Corporation Information
Table 145. Merck Description and Overview
Table 146. Merck Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 147. Merck Antiviral Drugs Product and Services
Table 148. Merck Antiviral Drugs SWOT Analysis
Table 149. Merck Recent Developments
Table 150. Novartis Corporation Information
Table 151. Novartis Description and Overview
Table 152. Novartis Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 153. Novartis Antiviral Drugs Product and Services
Table 154. Novartis Antiviral Drugs SWOT Analysis
Table 155. Novartis Recent Developments
Table 156. Bristol-Myers Squibb Corporation Information
Table 157. Bristol-Myers Squibb Description and Overview
Table 158. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 159. Bristol-Myers Squibb Antiviral Drugs Product and Services
Table 160. Bristol-Myers Squibb Antiviral Drugs SWOT Analysis
Table 161. Bristol-Myers Squibb Recent Developments
Table 162. Gilead Sciences Corporation Information
Table 163. Gilead Sciences Description and Overview
Table 164. Gilead Sciences Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 165. Gilead Sciences Antiviral Drugs Product and Services
Table 166. Gilead Sciences Antiviral Drugs SWOT Analysis
Table 167. Gilead Sciences Recent Developments
Table 168. GlaxoSmithKline Corporation Information
Table 169. GlaxoSmithKline Description and Overview
Table 170. GlaxoSmithKline Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 171. GlaxoSmithKline Antiviral Drugs Product and Services
Table 172. GlaxoSmithKline Antiviral Drugs SWOT Analysis
Table 173. GlaxoSmithKline Recent Developments
Table 174. AbbVie Corporation Information
Table 175. AbbVie Description and Overview
Table 176. AbbVie Antiviral Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 177. AbbVie Antiviral Drugs Product and Services
Table 178. AbbVie Antiviral Drugs SWOT Analysis
Table 179. AbbVie Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Antiviral Drugs Distributors List
Table 183. Antiviral Drugs Customers List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiviral Drugs Product Picture
Figure 2. Global Antiviral Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Reverse Transcriptase Inhibitors Product Picture
Figure 4. Protease Inhibitors Product Picture
Figure 5. Fusion Inhibitors Product Picture
Figure 6. Immune System Modulators Product Picture
Figure 7. Global Antiviral Drugs Sales Market Share by Application in 2021 & 2028
Figure 8. Hepatitis Therapeutics Use Case
Figure 9. HIV/AIDS Therapeutics Use Case
Figure 10. Herpes Therapeutics Use Case
Figure 11. Influenza Therapeutics Use Case
Figure 12. Antiviral Drugs Report Years Considered
Figure 13. Global Antiviral Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Antiviral Drugs Market Size 2017-2028 (US$ Million)
Figure 15. Global Antiviral Drugs Sales (2017-2022) & (K Units)
Figure 16. Global Antiviral Drugs Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Antiviral Drugs Sales Market Share by Region (2017-2022)
Figure 18. Global Antiviral Drugs Sales Market Share by Region in 2021
Figure 19. Global Antiviral Drugs Revenue Market Share by Region in 2017 VS 2021
Figure 20. Global Antiviral Drugs Sales Share by Manufacturers in 2021
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Antiviral Drugs Sales in 2021
Figure 22. Antiviral Drugs Revenue Share by Manufacturers in 2021
Figure 23. Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 24. Global Antiviral Drugs Revenue Share by Type (2017-2022)
Figure 25. Global Antiviral Drugs Revenue Growth Rate by Type in 2017 & 2021
Figure 26. Global Antiviral Drugs Revenue Share by Application (2017-2022)
Figure 27. Global Antiviral Drugs Revenue Growth Rate by Application in 2017 & 2021
Figure 28. North America Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 29. North America Antiviral Drugs Revenue Market Share by Type (2017-2028)
Figure 30. North America Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 31. North America Antiviral Drugs Revenue Market Share by Application (2017-2028)
Figure 32. North America Antiviral Drugs Sales Share by Country (2017-2028)
Figure 33. North America Antiviral Drugs Revenue Share by Country (2017-2028)
Figure 34. U.S. Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 35. Canada Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 36. Europe Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 37. Europe Antiviral Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Europe Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 39. Europe Antiviral Drugs Revenue Market Share by Application (2017-2028)
Figure 40. Europe Antiviral Drugs Sales Share by Country (2017-2028)
Figure 41. Europe Antiviral Drugs Revenue Share by Country (2017-2028)
Figure 42. Germany Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. France Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. U.K. Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Italy Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Russia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. Asia Pacific Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 48. Asia Pacific Antiviral Drugs Revenue Market Share by Type (2017-2028)
Figure 49. Asia Pacific Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 50. Asia Pacific Antiviral Drugs Revenue Market Share by Application (2017-2028)
Figure 51. Asia Pacific Antiviral Drugs Sales Share by Region (2017-2028)
Figure 52. Asia Pacific Antiviral Drugs Revenue Share by Region (2017-2028)
Figure 53. China Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Japan Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. South Korea Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. India Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Australia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Taiwan Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Indonesia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Thailand Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Malaysia Antiviral Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Philippines Antiviral Drugs Revenue (2017-2028) & (US$ Mill

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group2076488

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Influenza (Flu) Antiviral Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Report Scope This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access...
Global Novel Antiviral Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inh...
Global Influenza Antiviral Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Influenza Antiviral Drugs estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a...
Global Direct-acting Antiviral Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Direct-acting Antiviral Drugs estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing ...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *